Krishna Institute of Medical Sciences Reports Q1FY26 Revenue Growth of 26.8% and EBITDA Growth of 8.5%

Krishna Institute of Medical Sciences Ltd (KIMS Hospitals) announced its unaudited financial results for the first quarter of the financial year 2026, ended on 30th June 2025. The total revenue stood at INR 879 Cr, marking a growth of 26.8% on a year-on-year (YoY) basis and 9.6% on a quarter-on-quarter (QoQ) basis. The EBITDA was INR 200 Cr, with a growth of 8.5% YoY and a de-growth of 1.4% QoQ. The EBITDA margin stood at 22.7%. The Profit After Tax (PAT) was INR 85 Cr, down from INR 95 Cr and INR 106 Cr in Q1 FY25 and Q4 FY25 respectively. The consolidated EPS for Q1 FY26 was INR 1.96, a degrowth of 9.2% on a YoY basis. The cash and cash equivalents were INR 70 Cr as of Q1 FY26. The operational highlights included ARPOB growth of 11.8% and 3.7% on a YoY and QoQ basis, and ARPP growth of 9.8% and 2.7% on a YoY and QoQ basis.